Specifically, during the inspection at Duc Anh Pharmacy (belonging to Duc Anh Pharmaceutical and Medical Equipment Company Limited, located at 08 Huynh Thuc Khang Street, Lang Thuong Ward, Dong Da District, Hanoi), the authorities seized and tested 7 drug samples showing signs of serious violations.
 |
| Illustration photo. |
According to the test results of the Hanoi Center for Drug, Cosmetic and Food Testing, all 7 drug samples had no information about the circulation registration number or import license, and the manufacturing and importing facilities were unknown.
Notably, the drug sample DIAMICRON® MR 60mg (Gliklazid), batch number 23F603, expiry date 04/2026, only has a content of 42.5mg/tablet, which is 70.83% compared to the level declared on the label, not meeting the quality requirements according to the standards of the Vietnamese Pharmacopoeia V.
In addition to the above drug sample, the remaining samples include: Oseltamivir (batch number M1164B01, expiry date 03/2023), Crestor 20mg (Rosuvastatin, batch number A23237030, expiry date 04/2026), Janumet 50/1000mg (Sitagliptin/Metformin, batch number 24497505A, expiry date 07/2026), Plavix (Clopidogrel, batch number ELB04027, expiry date 05/2027), NEXIUM® 40mg (Esomeprazole, batch number 23H420, expiry date 09/2027) and Crestor 10mg (Rosuvastatin, batch number A24236004, expiry date 07/2027). All of them do not have legal documents proving their legal origin.
In this situation, the Drug Administration of Vietnam has requested the Hanoi Department of Health to urgently report to the City Steering Committee 389, coordinate with the Police, Market Management and relevant agencies to conduct a comprehensive inspection of the above-mentioned pharmacy's operations, and investigate and trace the origin of the 7 violating drug samples. The authorities are required to strictly handle the case according to current regulations and report the results to the Department before June 2, 2025.
At the same time, the Drug Administration also received a report from the Hanoi Testing Center about the discovery of a counterfeit drug called Theophylline Extended Release Tablets 200mg (Theophylin 200mg) at An An Pharmacy (No. 153, Group 14, Kien Hung Ward, Ha Dong District, Hanoi).
This drug sample has an active ingredient content of only 6.3% compared to the declared level, without a circulation registration number, import license or information about the importing facility. The label shows the name of the manufacturing unit as Pharmacy Laboratories Plus, an unclear name and not in the legal pharmaceutical management system in Vietnam.
The Drug Administration of Vietnam has issued an official dispatch requesting the Departments of Health nationwide to strengthen inspection and control of pharmaceutical business activities, especially at retail establishments, in order to promptly detect violating products. At the same time, this agency also recommends that people absolutely do not use the above drugs, only buy drugs at qualified pharmacies, have operating licenses and products of clear origin.
This is a move within the peak month of the fight against counterfeit drugs launched by the Government and the Ministry of Health . Detecting, seizing and handling counterfeit drugs and drugs of unknown origin is a necessary action to protect public health, maintain trust in the health system and ensure the rights of patients.
Source: https://baodautu.vn/phat-hien-thuoc-gia-va-thuoc-khong-ro-nguon-goc-tai-nha-thuoc-o-ha-noi-d293140.html
Comment (0)